124 related articles for article (PubMed ID: 18486725)
1. Chemotherapy for malignant pleural mesothelioma.
Vogelzang NJ
Lancet; 2008 May; 371(9625):1640-2. PubMed ID: 18486725
[No Abstract] [Full Text] [Related]
2. [Chemotherapy of malignant pleural mesothelioma: have we made any progress?].
Reck M; Heigener DF; Gatzemeier U
Zentralbl Chir; 2008 Jun; 133(3):238-42. PubMed ID: 18563688
[TBL] [Abstract][Full Text] [Related]
3. Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?
Rusch VW
J Clin Oncol; 2003 Jul; 21(14):2629-30. PubMed ID: 12860935
[No Abstract] [Full Text] [Related]
4. The new front line treatment for malignant pleural mesothelioma?
Steele JP
Thorax; 2003 Feb; 58(2):96-7. PubMed ID: 12554885
[No Abstract] [Full Text] [Related]
5. Chemotherapy of malignant pleural mesothelioma.
Bertino P; Carbone M; Pass H
Expert Opin Pharmacother; 2009 Jan; 10(1):99-107. PubMed ID: 19236184
[TBL] [Abstract][Full Text] [Related]
6. Systemic drug therapy of malignant pleural mesothelioma.
Ardizzoni A; Grossi F; Pennucci MC
Monaldi Arch Chest Dis; 1998 Apr; 53(2):236-40. PubMed ID: 9689814
[TBL] [Abstract][Full Text] [Related]
7. Trials in malignant mesothelioma. LCSG 851 and 882.
Rusch VW
Chest; 1994 Dec; 106(6 Suppl):359S-362S. PubMed ID: 7988264
[TBL] [Abstract][Full Text] [Related]
8. Current options for systemic therapy in mesothelioma.
Jackman DM
Semin Thorac Cardiovasc Surg; 2009; 21(2):154-8. PubMed ID: 19822287
[TBL] [Abstract][Full Text] [Related]
9. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Amicucci G
In Vivo; 2006; 20(6A):715-8. PubMed ID: 17203752
[TBL] [Abstract][Full Text] [Related]
10. Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.
Zucali PA; Simonelli M; Michetti G; Tiseo M; Ceresoli GL; Collovà E; Follador A; Lo Dico M; Moretti A; De Vincenzo F; Lorenzi E; Perrino M; Giordano L; Farina G; Santoro A; Garassino M
Lung Cancer; 2012 Mar; 75(3):360-7. PubMed ID: 21937142
[TBL] [Abstract][Full Text] [Related]
11. Need for further information on pemetrexed study.
Aelony Y
J Clin Oncol; 2004 Oct; 22(20):4234-5; author reply 4235-6. PubMed ID: 15483040
[No Abstract] [Full Text] [Related]
12. MVP and vinorelbine for malignant pleural mesothelioma.
Mordant P; Loriot Y; Soria JC; Deutsch E
Lancet; 2008 Aug; 372(9639):629; author reply 629-30. PubMed ID: 18722865
[No Abstract] [Full Text] [Related]
13. Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?
Li L; Razak AR; Hughes A
Lung Cancer; 2009 May; 64(2):207-10. PubMed ID: 18926592
[TBL] [Abstract][Full Text] [Related]
14. Review on clinical trials of targeted treatments in malignant mesothelioma.
Jakobsen JN; Sørensen JB
Cancer Chemother Pharmacol; 2011 Jul; 68(1):1-15. PubMed ID: 21553148
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052).
O'Brien ME; Gaafar RM; Popat S; Grossi F; Price A; Talbot DC; Cufer T; Ottensmeier C; Danson S; Pallis A; Hasan B; Van Meerbeeck JP; Baas P
Eur J Cancer; 2013 Sep; 49(13):2815-22. PubMed ID: 23791541
[TBL] [Abstract][Full Text] [Related]
16. Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma.
Woods B; Paracha N; Scott DA; Thatcher N
Lung Cancer; 2012 Feb; 75(2):261-7. PubMed ID: 21937141
[TBL] [Abstract][Full Text] [Related]
17. Pemetrexed in malignant pleural mesothelioma.
Hazarika M; White RM; Booth BP; Wang YC; Ham DY; Liang CY; Rahman A; Gobburu JV; Li N; Sridhara R; Morse DE; Lostritto R; Garvey P; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Feb; 11(3):982-92. PubMed ID: 15709163
[TBL] [Abstract][Full Text] [Related]
18. Population based epidemiology and prognosis of mesothelioma in Leeds, UK.
Chapman A; Mulrennan S; Ladd B; Muers MF
Thorax; 2008 May; 63(5):435-9. PubMed ID: 18202164
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for malignant pleural mesothelioma.
Janne PA
Clin Lung Cancer; 2003 Sep; 5(2):98-106. PubMed ID: 14596692
[TBL] [Abstract][Full Text] [Related]
20. Population-based survival for malignant mesothelioma after introduction of novel chemotherapy.
Damhuis RA; Schroten C; Burgers JA
Eur Respir J; 2012 Jul; 40(1):185-9. PubMed ID: 22135283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
